Active, Not Recruiting
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
NCT03405792
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma, WHO Grade IV, +8 more
- Locations
-
- University of Florida Health Gainesville, Florida, United States